THE MOST CENSORED WORK ONLINE!
Johnson and Johnson Appears to Have More Lawsuits than Drugs in Their Pipeline
The number of lawsuits against Johnson & Johnson continues to grow. Everything from faulty hips to baby carcinogens to vaginal mesh - the list of lawsuits may finally outweigh profits.
Date Created: March 23, 2012
Keywords: johnson and johnson lawsuits, lawsuits, drugs, pharma, fraud, false, marketing, advertising
Site accessed :
This page accessed 376 times.
Here we go... Time to start calculating what Alex Gorsky has cost Johnson & Johnson:
Keep in mind, Johnson & Johnson only has ONE source of income, the wallets of consumers who are their customers and shareholders - ultimately, the fines, restitution and long-term health consequences for their victims comes from inflating the price of their products: drugs, consumer goods, medical devices.
Risperdal: Courtesy of JNJ CEO Alex Gorsky - this corrupt mess was his project while in control at Janssen. Hard to believe this asshole is CEO. Was Billy-Boy Weldon in his right mind when he chose Alex as CEO?
Federal: $2,200,000,000 ($2.2 BILLION)
Arkansas: $1,200,000,000 ($1.2 BILLION)
South Carolina: $327,000,000 ($327 million)
Texas: $158,000,000 ($158 million)
Louisiana: $258,000,000 ($258 million)
36 states, class action: $181,000,000 ($181 million)
Kentucky: $ Currently in litigation
Wow - Risperdal alone has already cost Johnson & Johnson over $5 BILLION in litigation. This figure does not include lawyer fees and other fees associated with defending Johnson & Johnson for breaking laws and regulations designed to protect consumers from harm. However, profits were $24 billion from 2003 to 2010, quite a chunk of change for causing permanent harm, and deaths, from illegal marketing and misrepresentation of a harmful drug. Take off what was lost in litigation and the profit just doesn't seem as steep, especially when additional lawsuits continue to pile up.
Over $5 billion was needlessly added to the cost of our health care to cover this fiasco. Hence the high cost of health care...
Metal on Metal Hips:
It sure does look like Johnson & Johnson has wayyyyy more lawsuits than drugs in their pipeline...
INDEPENDENT AD-FREE WORK Most recent gift: 15 November 2023
This work is not
sponsored by bankers, lawyers, gov agencies, ad agencies or fraudsters.
Your gift, no matter the size, makes a real difference.
Please consider contributing today to help me continue work exposing fraud, corruption, coverups and harmful, defective and toxic products. Together, we can create a positive impact for improved health and well-being that lasts.
Thank you for your generosity,
PROCESSED ON TRANSACTION PROVIDER SECURE SERVERS
PayPal: Log in or scroll to bottom of PayPal transaction page and click "Pay with Debit or Credit Card"
1. Emily Patterson (2013, May 8). List of Reasons JNJ CEO Alex Gorsky Should Immediately Resign Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/alex_gorsky_resignation.shtml
2. Margaret Cronin Fisk, Jef Feeley and David Voreacos (2012, June 11). J&J Said to Agree to $2.2 Billion Drug Marketing Accord Bloomberg. Retrieved from http://www.bloomberg.com/news/2012-06-11/j-j-said-to-pay-2-2-billion-to-end-risperdal-sales-probe.html
CENSOR AVOIDANCE SYSTEM
Since I can't share my work on social media basically at all anymore, resorting to the last remaining free-ish solution to share my work: